Concepedia

Markov Cost-effectiveness Models

Markov Cost-Effectiveness Models is a type of stochastic state-transition model used in health economic evaluation that projects the progression of a population through a finite set of mutually exclusive health states over discrete time intervals, distinguishing itself by its reliance on the Markov property wherein the probability of transitioning to a future state depends only on the current state and not on the historical path of prior states.

305

Publications

11.8K

Citations

1.5K

Authors

690

Institutions

Publications per year

2017–2026

128

Parents

Publications

305

Bayesian approaches to multiple sources of evidence and uncertainty in complex cost‐effectiveness modelling

David J. Spiegelhalter, Nicola Best · Statistics in Medicine · 2003 · 235 citations

, , +17

Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations

Gunnel Ragnarson Tennvall, Jan Apelqvist · Diabetologia · 2001 · 229 citations · Full text

, , +14

Comparing Impact and Cost-Effectiveness of Primary Prevention Strategies for Lipid-Lowering

Mark J. Pletcher · Annals of Internal Medicine · 2009 · 191 citations

, , +17

Cost-Effectiveness of Implantable Cardioverter Defibrillators Relative to Amiodarone for Prevention of Sudden Cardiac Death

Douglas K Owens, Gillian D Sanders, Ryan A. Harris et al. · Annals of Internal Medicine · 1997 · 187 citations

, , +17

Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis

Thomas J. Hoerger, Russell Harris, Katherine A. Hicks et al. · Annals of Internal Medicine · 2004 · 181 citations

, , +17

1–5 of 305

Authors

1.5K

  1. JD
    Jeremy D. Goldhaber‐Fiebert

    Stanford University, United States

    6 publications · 403 citations

    6

    h-index

  2. AB
    Andrew Briggs

    University of Glasgow, United Kingdom

    5 publications · 329 citations

    5

    h-index

  3. KJ
    Kenneth J. Smith

    University of Pittsburgh, United States

    4 publications · 141 citations

    4

    h-index

  4. DL
    Danny Liew

    Monash University, Australia

    4 publications · 89 citations

    4

    h-index

  5. JL
    Johan L. Severens

    Maastricht University, Netherlands

    4 publications · 126 citations

    4

    h-index

1–5 of 1.5K

Institutions

690

  1. Stanford University

    Stanford, United States

    10 h-index

    47 publications

    2.7K citations

  2. London School of Hygiene & Tropical Medicine

    London, United Kingdom

    10 h-index

    18 publications

    651 citations

  3. Karolinska Institutet

    Stockholm, Sweden

    9 h-index

    24 publications

    1.8K citations

  4. Sichuan University

    Chengdu, China

    8 h-index

    37 publications

    565 citations

  5. University of York

    York, United Kingdom

    8 h-index

    17 publications

    522 citations

  6. University of Toronto

    Toronto, Canada

    8 h-index

    21 publications

    515 citations

  7. Radboud University Medical Center

    Nijmegen, The Netherlands

    7 h-index

    19 publications

    557 citations

  8. Radboud University Nijmegen

    Nijmegen, The Netherlands

    7 h-index

    22 publications

    704 citations

1–8 of 690

Venues

  1. PLoS ONE

    15 publications · 471 citations

    14

    h-index

  2. Journal of Medical Economics

    JME · 11 publications · 266 citations

    11

    h-index

  3. PharmacoEconomics

    10 publications · 328 citations

    10

    h-index

  4. BMJ Open

    10 publications · 381 citations

    10

    h-index

  5. Medical Decision Making

    MDM · 11 publications · 494 citations

    10

    h-index

1–5